Trial · NCT07888088
Phase 1 Trial to Evaluate Safety and Immunogenicity of MVA-BN-EBV in Healthy Young Adults
NCT07888088, Phase 1, Not yet recruiting, Bavarian Nordic
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Phase 1 Trial to Evaluate Safety and Immunogenicity of MVA-BN-EBV in Healthy Young Adults. Trials, record NCT07888088. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07888088
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Phase 1 Trial to Evaluate Safety and Immunogenicity of MVA-BN-EBV in Healthy Young Adults
- NCT number
- NCT07888088
- Status
- Not yet recruiting
- Phases
- Phase 1
- Enrollment
- 15 participants, estimated
- Lead sponsor
- Bavarian Nordic
- Conditions
- Epstein Barr Virus (EBV) Infection
- Interventions
- MVA-BN-EBV, Placebo
- First posted
- 2026-10-22
- Last updated
- 2026-10-22
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of participants with Serious Adverse Events (SAEs) | From first vaccination through Week 8 | Any postvaccination SAE, regardless of relationship to trial vaccine, throughout the trial |
| Primary | Number of participants with a grade 3 or higher AEs assessed as related to trial vaccine | The day of or within 8 days after either vaccination | Any grade 3 or higher AEs assessed as related to trial vaccine through the EAP |
| Primary | Number of participants with any solicited local and/or systemic AEs for an 8 day period | The day of or within 8 days after either vaccination | Any solicited local and/or systemic AEs for an 8-day period (day of vaccination plus 7 days) |
| Primary | Number of participants with any postvaccination MAAEs | From first vaccination through the end of the trial at Week 32 (v5) | Any postvaccination MAAEs, regardless of relationship to trial vaccine, throughout the trial |
| Primary | Number of participants with any postvaccination AESI | From first vaccination through the end of the trial at Week 32 (v5) | Any postvaccination AESI, regardless of relationship to trial vaccine, throughout the trial |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07888088
GET https://conductscience.org/api/trials/v1/NCT07888088/registered